The latest news about the CMCiB. For more news of research at the IGTP, please see our main website.
News
The Catalan Minister Nadal highlights "the uniqueness" of facilities like the Comparative Medicine and Bioimage Centre in the research system that promotes "biomedical innovation"
The Catalan Minister of Research and Universities meets with the management team of the CMCiB, which is one of the strategic projects driven by the Germans Trias i Pujol Research Institute (IGTP).
IGTP introduces super-resolution microscope at CMCiB
A state-of-the-art super-resolution fluorescence confocal microscope, called Abberior Infinity, was installed in the high-level biosafety (NCB3) facility of the Centre for Comparative Medicine and Bioimage (CMCiB). The equipment of this class, unique in the region, is a powerful tool for anyone aiming to perform advanced microscopy studies on fully infectious Level 3 pathogens (HIV, SARS-CoV-2, Monkey Pox, TB etc.) The microscope is available for use by all internal and external users via IGTP Microscopy Platform.
CMCiB participates in the preclinical studies of Rob Surgical's surgical robot, the first one designed and manufactured in Catalonia
The centre reaches a milestone in its track-record by adding the first Good Laboratory Practice study in its portfolio where the tested product at the centre will reach clinical trials in humans in accordance with international Good Clinical Practice.
Nine IGTP researchers participated in the 5th Edition of #100tífiques
The #100tífiques 2023 event was held with the participation of 573 women researchers. They gave simultaneous talks during the morning to around 40,000 students aged 11 to 13 across 505 Catalan schools. The purpose of the event is to encourage children to pursue scientific and technical careers while fostering a community of shared interests between academics and industry professionals. Nine scientists working at the Germans Trias i Pujol Institute (IGTP) took part in the event.
The IGTP coordinating two out of nine COST Actions coming to Spain and participating in a third
The COST Programme (European Cooperation in Science and Technology) has approved 70 new actions and Spain is coordinating nine of them, making it second in the ranking of countries leading COST Actions after Italy, which is coordinating ten. Three of the Spanish projects are from the Germans Trias i Pujol Research Institute (IGTP) and two of these are being led by the IGTP. COST Actions run for four years and this round will start in the coming autumn.
Bioimplants with extra-cellular vesicles from stem cells can improve cardiac function after an acute myocardial heart attack
Researchers from the ICREC Group (Cardiac Insufficiency and Regeneration) in cardiovascular diseases at the Germans Trias i Pujol Research Institute (IGTP) continue to work on therapeutic technologies to repair cardiac tissue after a heart attack. In an article published in Theranostics, they present a study of extracellular vesicles from mesenchymal stem cells combined with tissue engineering as a therapy to repair the heart after a heart attack. They have carried out the study on a porcine heart attack model at the Centre for Comparative Medicine and Bioimage (CMCiB) at the IGTP.